Table of Contents
Thrombosis
Volume 2014 (2014), Article ID 302861, 6 pages
http://dx.doi.org/10.1155/2014/302861
Research Article

New Thrombotic Events in Ischemic Stroke Patients with Elevated Factor VIII

1Stroke Program, Department of Neurology, Tulane University School of Medicine, 1440 Canal Street, TB-52, Suite 1000, New Orleans, LA 70112-2715, USA
2Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, 630 West 168 Street, New York, NY 10032, USA
3Stroke Program, Department of Neurology, Hospital of the University of Pennsylvania, 3400 Spruce Street, 2nd Floor, Ravdin Building, Philadelphia, PA 19104, USA
4Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL 35294, USA
5Health Services and Outcomes Research Center for Outcome and Effectiveness Research and Education (COERE), 1530 3rd Avenue South, Medical Towers, Birmingham, AL 35294, USA
6Center of Excellence in Comparative Effectiveness Research for Eliminating Disparities (CERED), Medical Towers Building, 1717 11th Avenue South, Suite 516A, Birmingham, AL 35294, USA
7Section on Statistical Genetics, Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL 35294, USA
8Section of Hematology/Oncology, Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, USA

Received 19 September 2014; Revised 22 November 2014; Accepted 22 November 2014; Published 17 December 2014

Academic Editor: Domenico Prisco

Copyright © 2014 Brittany M. Gouse et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Kraaijenhagen, P. S. In 'T Anker, M. M. W. Koopman et al., “High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism,” Thrombosis and Haemostasis, vol. 83, no. 1, pp. 5–9, 2000. View at Google Scholar · View at Scopus
  2. T. Koster, A. D. Blann, E. Briet, J. P. Vandenbroucke, and F. R. Rosendaal, “Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis,” The Lancet, vol. 345, no. 8943, pp. 152–155, 1995. View at Google Scholar · View at Scopus
  3. F. Öner Erkekol, A. Ulu, N. Numanoglu, and N. Akar, “High plasma levels of factor VIII: an important risk factor for isolated pulmonary embolism,” Respirology, vol. 11, no. 1, pp. 70–74, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Tanis, A. Algra, Y. Van Der Graaf, F. Helmerhorst, and F. Rosendaal, “Procoagulant factors and the risk of myocardial infarction in young women,” European Journal of Haematology, vol. 77, no. 1, pp. 67–73, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. T. W. Meade, J. A. Cooper, Y. Stirling, D. J. Howarth, V. Ruddock, and G. J. Miller, “Factor VIII, ABO blood group and the incidence of ischaemic heart disease,” British Journal of Haematology, vol. 88, no. 3, pp. 601–607, 1994. View at Google Scholar · View at Scopus
  6. A. R. Folsom, W. D. Rosamond, E. Shahar et al., “Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators,” Circulation, vol. 100, no. 7, pp. 736–742, 1999. View at Google Scholar
  7. T. R. Chang, K. C. Albright, A. K. Boehme et al., “Factor VIII in the setting of acute ischemic stroke among patients with suspected hypercoagulable state,” Clinical and Applied Thrombosis/Hemostasis, vol. 20, no. 2, pp. 124–128, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. A. D. Lopez, C. D. Mathers, M. Ezzati, D. T. Jamison, and C. J. Murray, “Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data,” The Lancet, vol. 367, no. 9524, pp. 1747–1757, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. E. Siegler, A. K. Boehme, A. M. Dorsey et al., “A comprehensive stroke center registry: advantages, limitations, and lessons learned,” Medical Student Research Journal, vol. 1, pp. 21–29, 2013. View at Google Scholar
  10. H. P. Adams Jr., B. H. Bendixen, L. J. Kappelle et al., “Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial,” Stroke, vol. 24, no. 1, pp. 35–41, 1993. View at Google Scholar · View at Scopus
  11. K. C. Albright, S. Martin-Schild, H. J. Bockholt et al., “No consensus on definition criteria for stroke registry common data elements,” Cerebrovascular Diseases Extra, vol. 1, pp. 84–92, 2011. View at Google Scholar
  12. J. E. Siegler, A. K. Boehme, K. C. Albright et al., “A proposal for the classification of etiologies of neurologic deterioration after acute ischemic stroke,” Journal of Stroke and Cerebrovascular Diseases, vol. 22, no. 8, pp. e549–e556, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. R. L. McNamara, L. M. Brass, J. P. Drozda Jr. et al., “ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on clinical data standards (writing commitee to develop data standards on atrial fibrillation),” Journal of the American College of Cardiology, vol. 44, no. 2, pp. 475–495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. D. W. Ramzi and K. V. Leeper, “DVT and pulmonary embolism: part I. Diagnosis,” American Family Physician, vol. 69, no. 12, pp. 2829–2836, 2004. View at Google Scholar · View at Scopus
  15. R. Bender and S. Lange, “Adjusting for multiple testing—when and how?” Journal of Clinical Epidemiology, vol. 54, no. 4, pp. 343–349, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. J. O'Donnell, A. D. Mumford, R. A. Manning, and M. Laffan, “Elevation of FVIII:C in venous thromboembolism is persistent and independent of the acute phase response,” Thrombosis and Haemostasis, vol. 83, no. 1, pp. 10–13, 2000. View at Google Scholar · View at Scopus
  17. P. W. Kamphuisen, J. C. J. Eikenboom, H. L. Vos et al., “Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions,” Thrombosis and Haemostasis, vol. 81, no. 5, pp. 680–683, 1999. View at Google Scholar · View at Scopus
  18. C. Gustafsson, M. Blomback, M. Britton, A. Hamsten, and J. Svensson, “Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation,” Stroke, vol. 21, no. 1, pp. 47–51, 1990. View at Google Scholar · View at Scopus
  19. G. Landi, A. D'Angelo, E. Boccardi et al., “Hypercoagulability in acute stroke: prognostic significance,” Neurology, vol. 37, no. 10, pp. 1667–1671, 1987. View at Google Scholar · View at Scopus